EP2 Receptor Signaling Regulates Microglia Death

Area of Science:

• Neuroinflammation and Microglial Biology
• Cell Death Mechanisms in the Central Nervous System

Background:

• Resolution of brain inflammation is crucial to prevent tissue damage.
• Microglial apoptosis is a proposed mechanism for resolving neuroinflammation, but its regulation is unclear.
• Previous work identified cyclooxygenase-2 (COX-2) as a key factor in lipopolysaccharide (LPS) and interleukin (IL)-13-induced microglial death.

Purpose of the Study:

• To elucidate the role of the E prostanoid receptor 2 (EP2) in regulating microglial death.
• To investigate the signaling pathways involved in EP2-mediated microglial death.
• To explore the potential contribution of EP2-driven microglial apoptosis to neuroinflammation resolution.

Main Methods:

• Primary rat microglia cultures were treated with LPS, IL-13, EP2 agonists/antagonists, and other signaling modulators.
• Microglial death was assessed using cell viability assays.
• Expression of COX-2, heme oxygenase 1 (Hmox1), and caspases (caspase-1, activated caspase-3) was analyzed at mRNA and protein levels.

Main Results:

• EP2 activation by prostaglandin E2 or agonists mediated microglial death induced by LPS/IL-13 and also killed microglia directly.
• EP2 activation increased the expression of COX-2 and Hmox1, while reactive oxygen scavengers and Hmox1 inducers (cobalt protoporphyrin, carbon monoxide) attenuated microglial death.
• Evidence suggested both pyroptotic (caspase-1 dependent) and apoptotic (caspase-3 dependent) death pathways were involved in EP2-mediated microglial death.

Conclusions:

• EP2 activation plays a dual role, initially activating and subsequently inducing the death of microglia.
• This EP2-mediated microglial death involves COX-2, reactive oxygen species, and Hmox1, with potential contributions from pyroptosis and apoptosis.
• Targeting the EP2 pathway may offer a novel strategy for resolving neuroinflammation by promoting the clearance of activated microglia.